SH3KBP1 and central nervous system cancer: In addition, we performed Kaplan-Meier survival analysis in TCGA data set and the results showed a statistically significant worse prognosis for glioma patients with higher expression of SH3KBP1 compared with lower SH3KBP1 group patients (Figure 1B).